Leadership & Pay ·
Vera Therapeutics, Inc. announced a leadership transition in its regulatory department, with William Turner…
VERAVera Therapeutics, Inc.
Vera Therapeutics, Inc. announced a leadership transition in its regulatory department, with William Turner transitioning to Special Advisor for Regulatory Affairs effective August 3, 2026, and Nancy Bowman, M.D., Ph.D., succeeding him as Chief Regulatory Officer. Vera Therapeutics, Inc. is a biotechnology company focused on developing therapeutic solutions for immune-mediated diseases.